Abstract
The plasma levels of free oxysterols (7-ketocholesterol: 7α-hydroxy-, 7β-hydroxy-, 25-hydroxy-, and 27-hydroxycholesterol; and 5α,6α-epoxycholestanol) in patients with diabetes mellitus and hypercholesterolemia were determined using gas chromatography-mass spectrometry with selective ion monitoring. We studied 39 patients with diabetes mellitus, 20 nondiabetic patients with hypercholesterolemia, and 37 normal controls. Plasma cholesterol levels in diabetic and hypercholesterolemic patients showed no statistical difference. Plasma 7-ketocholesterol was significantly higher in patients with diabetes (31.6±2.8 ng/mL) or hypercholesterolemia (52.3±5.9) than in the control group (22.4±1.2). The increased plasma cholesterol can be regarded as an oxidation substrate for the oxidant stress and the higher absolute levels of oxysterols in hypercholesterolemic plasma compared with the control plasma. This difference disappeared when 7-ketocholesterol was expressed in proportion to total cholesterol. The oxidizability of plasma cholesterol was evaluated by comparing the increased ratio of 7-ketocholesterol after CuSO4 oxidation to the ratio before. We demonstrated that the patients with diabetes showed increased oxidizability (77.5%) compared with the control (36.6%) or hyperlipemic group (45.3%), which is likely due to the lower amounts of α-tocopherol in the diabetics. Measurement of oxysterols may serve as a marker for in vivo oxidized lipoproteins in diabetes and hyperlipemia.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
Abbreviations
- Cholestane-3β:
-
6α-diol, 5α-cholestane-3β,6α-diol
- cholesterol:
-
cholest-5-en-3β-ol
- CV:
-
coefficient of variation
- DM:
-
diabetes mellitus
- 5α,6α:
-
epoxycholestanol, 5,6α-epoxy-5α-cholestan-3β-ol
- GC-MS:
-
gas chromatography-mass spectrometry
- HbAlc:
-
glycosylated hemoglobin
- HL:
-
hypercholesterolemia
- α-hydroxycholesterol:
-
cholest-5-ene-3β,7α-diol
- 7β-hydroxycholesterol:
-
cholest-5-ene-3β7β-diol
- 25-hydroxycholesterol:
-
cholest-5-ene-3β,25-diol
- 27-hydroxycholesterol:
-
cholest-5-ene-3β,27-diol
- 7-ketocholesterol:
-
3β-hydroxycholes-5-en-7-one
- LDL:
-
low density lipoprotein
- SIM:
-
selective ion monitoring
- TC:
-
total cholesterol
- TG:
-
triglyceride
- TMS:
-
ether, trimethylsilyl ether
References
Steinberg, D., Parthasarathy, S., Carew, T.E., Khoo, J.C., and Witztum, J.L. (1989) Beyond Cholesterol, Modifications of Low-Density Lipoprotein That Increase Its Atherogenicity, N. Engl. J. Med. 320, 915–924.
Bhadra, S., Arshad, M.A.Q., Rymaszewski, Z., Norman, E., Wherley, R., and Subbiah, M.T.R. (1991) Oxidation of Cholesterol Moiety of Low Density Lipoprotein in the Presence of Human Endothelial Cells of CuSO4 (II) Ions: Identification of Major Products and Their Effects, Biochem. Biophys. Res. Commun. 176, 431–440.
Carpenter, K.L., Wilkins, G.M., Fussell, B., Ballantine, J.A., Taylor, S.E., Mitchinson, M.J., and Leak, D.S. (1994) Production of Oxidized Lipids During Modification of Low-Density Lipoproteins, Biochem. J. 304, 625–633.
Hodis, H.N., Crawford, D.W., and Sevanian, A. (1991) Cholesterol Feeding Increases Plasma and Aortic Tissue Cholesterol Oxide Levels in Parallel: Further Evidence for the Role of Cholesterol Oxidation in Atherosclerosis, Atherosclerosis 89, 117–126.
Hessler, J.R., Morel, D.W., Lewis, L.J., and Chisolm, G.M. (1983) Lipoprotein Oxidation and Lipoprotein-Induced Cytotoxicity, Atherosclerosis 3, 215–222.
Brown, M.S., and Goldstein, J.L. (1983) Beyond Cholesterol. Modification of Low-Density Lipoprotein That Increases Its Atherogenicity, Annu. Rev. Biochem. 52, 223–261.
Jacobson, M.S. (1987) Cholesterol Oxides in Indian Ghee: Possible Cause of Unexpected High Risk of Atherosclerosis in Indian Immigrant Populations, Lancet 2, 656–658.
Esterbauer, H., and Jurgens, G. (1993) Mechanistic and Genetic Aspects of Susceptibility of LDL to Oxidation, Curr. Opin. Lipidol. 4, 114–124.
Esterbauer, H., Striegl, G., Puhl, H., and Rotheneder, M. (1989) Continuous Monitoring of in vitro Oxidation of Human Low-Density Lipoprotein, Free Radical Res. Commun. 6, 67–75.
Smith, L.L. (1981) Distribution of Autoxidation Products, in Cholesterol Autoxidation (Smith, L.L., ed.), pp. 49–124, Plenum Press, New York.
Bjorkhem, I. (1985) Mechanism of Bile Acid Biosynthesis in Mammalian Liver, in Sterols and Bile Acids (Danielsson, H., and Sjovall, J., eds.), pp. 231–278, Elsevier, Amsterdam.
Bjorkhem, L., Andersson, O., Diczfalusy, U., Sevastik, B., Xiu, R.J., and Lund, E. (1994) Atherosclerosis and Sterol 27-Hydroxylase: Evidence for a Role of This Enzyme in Elimination of Cholesterol from Human Macrophages, Proc. Natl. Acad. Sci. USA 91, 8592–8596.
Smith, L.L., and Johnson, B.H. (1989) Biological Activities of Oxysterols, Free Radical Biol. Med. 7, 285–332.
Kosugi, K., Morel, D.W., Dicorleto, P.E., and Chisolm, G.M. (1987) Toxicity of Oxidized Low-Density Lipoprotein to Cultured Fibroblasts is Selective for S Phase of the Cell Cycle, J. Cell Physiol. 130, 311–320.
Chen, H.W., Kandutsch, A.A., and Waymouth, C. (1974) Inhibition of Cell Growth by Oxygenated Derivatives of Cholesterol, Nature 251, 419–421.
Richert, L., Castagna, M., Beck, J.P., Rong, S., Luu, B., and Ourisson, G. (1984) Growth Rate-Related and Hydroxysterol-Induced Changes in Membrane Fluidity of Cultured Hepatoma Cells: Correlation with 3-Hydroxy-3-methyl-glutaryl CoA Reductase Activity, Biochem. Biophys. Res. Commun. 120, 192–198.
Dzeletovic, S., Breuer, O., Lund, E., and Diczfalusy, U. (1995) Determinant of Cholesterol Oxidation Products in Human Plasma by Isotope Dilution-Mass Spectrometry, Anal. Biochem. 225, 73–80.
Van Lier, J.E., and Smith, L.L. (1967) Sterol Metabolism. 1. 26-Hydroxycholesterol in the Human Aorta, Biochemistry 6, 3269–3278.
Maerker, G., and Unruh, J. (1986) Cholesterol Oxides. 1. Isolation and Determination of Some Cholesterol Oxidation Products, J. Am. Oil. Chem. Soc. 63, 767–771.
Schuh, J., Fairclough, G.F., and Haschemeyer, R.H. (1978) Oxygen-Mediated Heterogeneity of Apo-low-density Lipoprotein, Proc. Natl. Acad. Sci. USA 75, 3173–3177.
Yagi, K. (1987) Lipid Peroxides and Human Diseases, Chem. Phys. Lipids 45, 337–351.
Hodis, H.N., Kramsch, D.M., Avogaro, P., Bittolo-Bon, G., Hwang, J., Peterson, H., and Sevanian, A. (1994) Biochemical and Cytotoxic Characteristics of an in vivo Circulating Oxidized Low Density Lipoprotein (LDL), J. Lipid Res. 35, 669–677.
Sevanian, A., Bittolo-Bon, G., Cazzolato, G., Hodis, H., Hwang, J., Zamburlini, A., Mariorino, M., and Ursin, F. (1997) LDL Is a Lipid Hydroperoxide-Enriched Circulating Lipoprotein, J. Lipid Res. 38, 419–428.
Henriksen, T., Mahoney, E.M., and Steinberg, D. (1981) Enhanced Macrophage Degradation of Low-Density Lipoprotein Previously Incubated with Cultured Endothelial Cells: Recognition by Receptors for Acetylated Low-Density Lipoproteins, Proc. Natl. Acad. Sci. USA 78, 6499–6503.
Mullarkey, C.J., Edelstein, D., and Brownlee, M. (1990) Free Radical Generation by Early Glycation Products: A Mechanism for Accelerated Atherogenesis in Diabetes, Biochem. Biophys. Res. Commun. 173, 932–939.
Hunt, J.V., Smith, C.C., and Wolff, S.P. (1990) Autoxidative Glycosylation and Possible Involvement of Peroxides and Free Radicals in LDL Modification by Glucose, Diabetes 39, 1420–1424.
Griesmacher, A., Kindhauser, M., Andert, S.E., Schreiner, W., Toma, C., Knobl, P., Pietschmann, P., Prager, R., Schnack, C., and Schernthaner, G. (1995) Enhanced Serum Levels of Thiobarbituric-Acid-Reactive Substances in Diabetes Mellitus, Am. J. Med. 98, 469–475.
Mol, M.J., Rijke, Y.B., Demacker, P.N., and Stalenhoef, A.F. (1997) Plasma Levels of Lipid and Cholesterol Oxidation Products and Cytokines in Diabetes Mellitus and Cigarette Smoking: Effects of Vitamin E Treatment, Atherosclerosis 129, 169–176.
Austin, M.A., and Edwards, K.L. (1996) Small, Dense Low Density Lipoproteins, the Insulin Resistance Syndrome and Noninsulin-Dependent Diabetes, Curr. Opin. Lipidol. 7, 167–171.
Matkovics, B., Varga, S.I., Szabo, L., and Witas, H. (1982) The Effect of Diabetes on the Activities of the Peroxide Metabolism Enzymes, Horm. Metab. Res. 14:77–79.
Jialal, I., Freeman, D.A., and Grundy, S.M. (1991) Varying Susceptibility of Different Low Density Lipoproteins to Oxidative Modification, Arterioscler. Thromb. 11, 482–488.
Author information
Authors and Affiliations
About this article
Cite this article
Murakami, H., Tamasawa, N., Matsui, J. et al. Plasma oxysterols and tocopherol in patients with diabetes mellitus and hyperlipidemia. Lipids 35, 333–338 (2000). https://doi.org/10.1007/s11745-000-0530-1
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/s11745-000-0530-1